IL6 and prostate carcinoma: Also, inhibition of IL-6-JAK/STAT3 signalling result in the enhancement of NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels, in castration-resistant prostate cancer cells (82).